Global Prostate Cancer Market Research Report 2023

Prostate cancer is cancer that occurs in the prostate.

The global Prostate Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Prostate Cancer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Prostate Cancer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Prostate Cancer in Age Below 55 is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Prostate Cancer include Astellas, Inc., AstraZeneca plc, Johnson & Johnson, Sanofi S.A, Bristol Myers Squibb (BMS) and Bayer AG, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Prostate Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer.

The Prostate Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Prostate Cancer market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prostate Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prostate Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Chemotherapy

1.2.3 Hormonal Therapy

1.2.4 Targeted Therapy

1.2.5 Immunotherapy

1.3 Market by Application

1.3.1 Global Prostate Cancer Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Age Below 55

1.3.3 Age 55-75

1.3.4 Age Above 75

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Prostate Cancer Market Perspective (2018-2029)

2.2 Prostate Cancer Growth Trends by Region

2.2.1 Global Prostate Cancer Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Prostate Cancer Historic Market Size by Region (2018-2023)

2.2.3 Prostate Cancer Forecasted Market Size by Region (2024-2029)

2.3 Prostate Cancer Market Dynamics

2.3.1 Prostate Cancer Industry Trends

2.3.2 Prostate Cancer Market Drivers

2.3.3 Prostate Cancer Market Challenges

2.3.4 Prostate Cancer Market Restraints

3.1 Global Top Prostate Cancer Players by Revenue

3.1.1 Global Top Prostate Cancer Players by Revenue (2018-2023)

3.1.2 Global Prostate Cancer Revenue Market Share by Players (2018-2023)

3.2 Global Prostate Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Prostate Cancer Revenue

3.4 Global Prostate Cancer Market Concentration Ratio

3.4.1 Global Prostate Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Revenue in 2022

3.5 Prostate Cancer Key Players Head office and Area Served

3.6 Key Players Prostate Cancer Product Solution and Service

3.7 Date of Enter into Prostate Cancer Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Prostate Cancer Historic Market Size by Type (2018-2023)

4.2 Global Prostate Cancer Forecasted Market Size by Type (2024-2029)

5.1 Global Prostate Cancer Historic Market Size by Application (2018-2023)

5.2 Global Prostate Cancer Forecasted Market Size by Application (2024-2029)

6.1 North America Prostate Cancer Market Size (2018-2029)

6.2 North America Prostate Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Prostate Cancer Market Size by Country (2018-2023)

6.4 North America Prostate Cancer Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Prostate Cancer Market Size (2018-2029)

7.2 Europe Prostate Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Prostate Cancer Market Size by Country (2018-2023)

7.4 Europe Prostate Cancer Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Prostate Cancer Market Size (2018-2029)

8.2 Asia-Pacific Prostate Cancer Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Prostate Cancer Market Size by Region (2018-2023)

8.4 Asia-Pacific Prostate Cancer Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Prostate Cancer Market Size (2018-2029)

9.2 Latin America Prostate Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Prostate Cancer Market Size by Country (2018-2023)

9.4 Latin America Prostate Cancer Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Prostate Cancer Market Size (2018-2029)

10.2 Middle East & Africa Prostate Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Prostate Cancer Market Size by Country (2018-2023)

10.4 Middle East & Africa Prostate Cancer Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Astellas, Inc.

11.1.1 Astellas, Inc. Company Detail

11.1.2 Astellas, Inc. Business Overview

11.1.3 Astellas, Inc. Prostate Cancer Introduction

11.1.4 Astellas, Inc. Revenue in Prostate Cancer Business (2018-2023)

11.1.5 Astellas, Inc. Recent Development

11.2 AstraZeneca plc

11.2.1 AstraZeneca plc Company Detail

11.2.2 AstraZeneca plc Business Overview

11.2.3 AstraZeneca plc Prostate Cancer Introduction

11.2.4 AstraZeneca plc Revenue in Prostate Cancer Business (2018-2023)

11.2.5 AstraZeneca plc Recent Development

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Detail

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Prostate Cancer Introduction

11.3.4 Johnson & Johnson Revenue in Prostate Cancer Business (2018-2023)

11.3.5 Johnson & Johnson Recent Development

11.4 Sanofi S.A

11.4.1 Sanofi S.A Company Detail

11.4.2 Sanofi S.A Business Overview

11.4.3 Sanofi S.A Prostate Cancer Introduction

11.4.4 Sanofi S.A Revenue in Prostate Cancer Business (2018-2023)

11.4.5 Sanofi S.A Recent Development

11.5 Bristol Myers Squibb (BMS)

11.5.1 Bristol Myers Squibb (BMS) Company Detail

11.5.2 Bristol Myers Squibb (BMS) Business Overview

11.5.3 Bristol Myers Squibb (BMS) Prostate Cancer Introduction

11.5.4 Bristol Myers Squibb (BMS) Revenue in Prostate Cancer Business (2018-2023)

11.5.5 Bristol Myers Squibb (BMS) Recent Development

11.6 Bayer AG

11.6.1 Bayer AG Company Detail

11.6.2 Bayer AG Business Overview

11.6.3 Bayer AG Prostate Cancer Introduction

11.6.4 Bayer AG Revenue in Prostate Cancer Business (2018-2023)

11.6.5 Bayer AG Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Prostate Cancer Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Chemotherapy

    Table 3. Key Players of Hormonal Therapy

    Table 4. Key Players of Targeted Therapy

    Table 5. Key Players of Immunotherapy

    Table 6. Global Prostate Cancer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Prostate Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Prostate Cancer Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Prostate Cancer Market Share by Region (2018-2023)

    Table 10. Global Prostate Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Prostate Cancer Market Share by Region (2024-2029)

    Table 12. Prostate Cancer Market Trends

    Table 13. Prostate Cancer Market Drivers

    Table 14. Prostate Cancer Market Challenges

    Table 15. Prostate Cancer Market Restraints

    Table 16. Global Prostate Cancer Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Prostate Cancer Market Share by Players (2018-2023)

    Table 18. Global Top Prostate Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer as of 2022)

    Table 19. Ranking of Global Top Prostate Cancer Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Prostate Cancer Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Prostate Cancer Product Solution and Service

    Table 23. Date of Enter into Prostate Cancer Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Prostate Cancer Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Prostate Cancer Revenue Market Share by Type (2018-2023)

    Table 27. Global Prostate Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Prostate Cancer Revenue Market Share by Type (2024-2029)

    Table 29. Global Prostate Cancer Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Prostate Cancer Revenue Market Share by Application (2018-2023)

    Table 31. Global Prostate Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Prostate Cancer Revenue Market Share by Application (2024-2029)

    Table 33. North America Prostate Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Prostate Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Prostate Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Prostate Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Prostate Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Prostate Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Prostate Cancer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Prostate Cancer Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Prostate Cancer Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Prostate Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Prostate Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Prostate Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Prostate Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Prostate Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Prostate Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Astellas, Inc. Company Detail

    Table 49. Astellas, Inc. Business Overview

    Table 50. Astellas, Inc. Prostate Cancer Product

    Table 51. Astellas, Inc. Revenue in Prostate Cancer Business (2018-2023) & (US$ Million)

    Table 52. Astellas, Inc. Recent Development

    Table 53. AstraZeneca plc Company Detail

    Table 54. AstraZeneca plc Business Overview

    Table 55. AstraZeneca plc Prostate Cancer Product

    Table 56. AstraZeneca plc Revenue in Prostate Cancer Business (2018-2023) & (US$ Million)

    Table 57. AstraZeneca plc Recent Development

    Table 58. Johnson & Johnson Company Detail

    Table 59. Johnson & Johnson Business Overview

    Table 60. Johnson & Johnson Prostate Cancer Product

    Table 61. Johnson & Johnson Revenue in Prostate Cancer Business (2018-2023) & (US$ Million)

    Table 62. Johnson & Johnson Recent Development

    Table 63. Sanofi S.A Company Detail

    Table 64. Sanofi S.A Business Overview

    Table 65. Sanofi S.A Prostate Cancer Product

    Table 66. Sanofi S.A Revenue in Prostate Cancer Business (2018-2023) & (US$ Million)

    Table 67. Sanofi S.A Recent Development

    Table 68. Bristol Myers Squibb (BMS) Company Detail

    Table 69. Bristol Myers Squibb (BMS) Business Overview

    Table 70. Bristol Myers Squibb (BMS) Prostate Cancer Product

    Table 71. Bristol Myers Squibb (BMS) Revenue in Prostate Cancer Business (2018-2023) & (US$ Million)

    Table 72. Bristol Myers Squibb (BMS) Recent Development

    Table 73. Bayer AG Company Detail

    Table 74. Bayer AG Business Overview

    Table 75. Bayer AG Prostate Cancer Product

    Table 76. Bayer AG Revenue in Prostate Cancer Business (2018-2023) & (US$ Million)

    Table 77. Bayer AG Recent Development

    Table 78. Research Programs/Design for This Report

    Table 79. Key Data Information from Secondary Sources

    Table 80. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Prostate Cancer Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Prostate Cancer Market Share by Type: 2022 VS 2029

    Figure 3. Chemotherapy Features

    Figure 4. Hormonal Therapy Features

    Figure 5. Targeted Therapy Features

    Figure 6. Immunotherapy Features

    Figure 7. Global Prostate Cancer Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Prostate Cancer Market Share by Application: 2022 VS 2029

    Figure 9. Age Below 55 Case Studies

    Figure 10. Age 55-75 Case Studies

    Figure 11. Age Above 75 Case Studies

    Figure 12. Prostate Cancer Report Years Considered

    Figure 13. Global Prostate Cancer Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Prostate Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Prostate Cancer Market Share by Region: 2022 VS 2029

    Figure 16. Global Prostate Cancer Market Share by Players in 2022

    Figure 17. Global Top Prostate Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Prostate Cancer Revenue in 2022

    Figure 19. North America Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Prostate Cancer Market Share by Country (2018-2029)

    Figure 21. United States Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Prostate Cancer Market Share by Country (2018-2029)

    Figure 25. Germany Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Prostate Cancer Market Share by Region (2018-2029)

    Figure 33. China Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Prostate Cancer Market Share by Country (2018-2029)

    Figure 41. Mexico Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Prostate Cancer Market Share by Country (2018-2029)

    Figure 45. Turkey Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Prostate Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Astellas, Inc. Revenue Growth Rate in Prostate Cancer Business (2018-2023)

    Figure 48. AstraZeneca plc Revenue Growth Rate in Prostate Cancer Business (2018-2023)

    Figure 49. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Business (2018-2023)

    Figure 50. Sanofi S.A Revenue Growth Rate in Prostate Cancer Business (2018-2023)

    Figure 51. Bristol Myers Squibb (BMS) Revenue Growth Rate in Prostate Cancer Business (2018-2023)

    Figure 52. Bayer AG Revenue Growth Rate in Prostate Cancer Business (2018-2023)

    Figure 53. Bottom-up and Top-down Approaches for This Report

    Figure 54. Data Triangulation

    Figure 55. Key Executives Interviewed